A novel Bayesian method for dual-agent Phase I dose-escalation studies using penalized D-optimality
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A novel Bayesian method for dual-agent Phase I dose-escalation studies using penalized D-optimality ; volume:14 ; number:1 ; day:29 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Trials ; 14, Heft 1 (29.11.2013), 1, 11.2013
- Urheber
-
Wheeler, Graham
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-14-S1-P41
- URN
-
urn:nbn:de:1111-2016050232684
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wheeler, Graham
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Nonparametric Bayesian hazard rate models based on penalized splines
Theoretical and practical contributions to Bayesian penalized spline regression
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Nonparametric Bayesian hazard rate models based on penalized splines
Theoretical and practical contributions to Bayesian penalized spline regression
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Nonparametric Bayesian hazard rate models based on penalized splines
Theoretical and practical contributions to Bayesian penalized spline regression
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine